Terms: = Breast cancer AND RANBP2, NUP358, 5903, ENSG00000153201, P49792, TRP1, TRP2
19 results:
1. Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in breast cancer.
Stella S; Vitale SR; Massimino M; Motta G; Longhitano C; Lanzafame K; Martorana F; Fazzari C; Vecchio GM; Tirrò E; Inzerilli N; Carciotto R; Manzella L; Caruso M; Vigneri P
Cancer Genomics Proteomics; 2022; 19(4):464-476. PubMed ID: 35732329
[TBL] [Abstract] [Full Text] [Related]
2. The ranbp2/RanGAP1-SUMO complex gates β-arrestin2 nuclear entry to regulate the Mdm2-p53 signaling axis.
Blondel-Tepaz E; Leverve M; Sokrat B; Paradis JS; Kosic M; Saha K; Auffray C; Lima-Fernandes E; Zamborlini A; Poupon A; Gaboury L; Findlay J; Baillie GS; Enslen H; Bouvier M; Angers S; Marullo S; Scott MGH
Oncogene; 2021 Mar; 40(12):2243-2257. PubMed ID: 33649538
[TBL] [Abstract] [Full Text] [Related]
3. TV-circRGPD6 Nanoparticle Suppresses breast cancer Stem Cell-Mediated Metastasis via the miR-26b/YAF2 Axis.
Lin X; Chen W; Wei F; Xie X
Mol Ther; 2021 Jan; 29(1):244-262. PubMed ID: 32950105
[TBL] [Abstract] [Full Text] [Related]
4. MTSS1 suppresses mammary tumor-initiating cells by enhancing RBCK1-mediated p65 ubiquitination.
Cong M; Wang Y; Yang Y; Lian C; Zhuang X; Li X; Zhang P; Liu Y; Tang J; Yang Q; Zhang X; Xiong H; Hu R; Hu G
Nat Cancer; 2020 Feb; 1(2):222-234. PubMed ID: 35122005
[TBL] [Abstract] [Full Text] [Related]
5. Tumor-Specific Regulatory T Cells from the Bone Marrow Orchestrate Antitumor Immunity in breast cancer.
Ge Y; Böhm HH; Rathinasamy A; Xydia M; Hu X; Pincha M; Umansky L; Breyer C; Hillier M; Bonertz A; Sevko A; Domschke C; Schuetz F; Frebel H; Dettling S; Herold-Mende C; Reissfelder C; Weitz J; Umansky V; Beckhove P
Cancer Immunol Res; 2019 Dec; 7(12):1998-2012. PubMed ID: 31672785
[TBL] [Abstract] [Full Text] [Related]
6. Chemical Antibody Mimics Inhibit Cadherin-Mediated Cell-Cell Adhesion: A Promising Strategy for cancer Therapy.
Medina Rangel PX; Moroni E; Merlier F; Gheber LA; Vago R; Tse Sum Bui B; Haupt K
Angew Chem Int Ed Engl; 2020 Feb; 59(7):2816-2822. PubMed ID: 31659849
[TBL] [Abstract] [Full Text] [Related]
7. Oncogenic potential of nucleoporins in non-hematological cancers: recent update beyond chromosome translocation and gene fusion.
Roy A; Narayan G
J Cancer Res Clin Oncol; 2019 Dec; 145(12):2901-2910. PubMed ID: 31654122
[TBL] [Abstract] [Full Text] [Related]
8. Melanogenesis-Inhibitory and Cytotoxic Activities of Limonoids, Alkaloids, and Phenolic Compounds from Phellodendron amurense Bark.
Akihisa T; Yokokawa S; Ogihara E; Matsumoto M; Zhang J; Kikuchi T; Koike K; Abe M
Chem Biodivers; 2017 Jul; 14(7):. PubMed ID: 28425165
[TBL] [Abstract] [Full Text] [Related]
9. Neddylation controls basal MKK7 kinase activity in breast cancer cells.
Zhu T; Wang J; Pei Y; Wang Q; Wu Y; Qiu G; Zhang D; Lv M; Li W; Zhang J
Oncogene; 2016 May; 35(20):2624-33. PubMed ID: 26364603
[TBL] [Abstract] [Full Text] [Related]
10. Limonoids from Azadirachta indica var. siamensis extracts and their cytotoxic and melanogenesis-inhibitory activities.
Manosroi A; Kitdamrongtham W; Ishii K; Shinozaki T; Tachi Y; Takagi M; Ebina K; Zhang J; Manosroi J; Akihisa R; Akihisa T
Chem Biodivers; 2014 Apr; 11(4):505-31. PubMed ID: 24706622
[TBL] [Abstract] [Full Text] [Related]
11. Targeting zinc finger domains with small molecules: solution structure and binding studies of the ranbp2-type zinc finger of RBM5.
Farina B; Fattorusso R; Pellecchia M
Chembiochem; 2011 Dec; 12(18):2837-45. PubMed ID: 22162216
[TBL] [Abstract] [Full Text] [Related]
12. The nucleoporin nup358/ranbp2 promotes nuclear import in a cargo- and transport receptor-specific manner.
Wälde S; Thakar K; Hutten S; Spillner C; Nath A; Rothbauer U; Wiemann S; Kehlenbach RH
Traffic; 2012 Feb; 13(2):218-33. PubMed ID: 21995724
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort.
McInerney NM; Miller N; Rowan A; Colleran G; Barclay E; Curran C; Kerin MJ; Tomlinson IP; Sawyer E
Breast Cancer Res Treat; 2010 May; 121(1):203-10. PubMed ID: 19763819
[TBL] [Abstract] [Full Text] [Related]
14. Supraphysiological nuclear export signals bind CRM1 independently of RanGTP and arrest at nup358.
Engelsma D; Bernad R; Calafat J; Fornerod M
EMBO J; 2004 Sep; 23(18):3643-52. PubMed ID: 15329671
[TBL] [Abstract] [Full Text] [Related]
15. Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.
Overwijk WW; Lee DS; Surman DR; Irvine KR; Touloukian CE; Chan CC; Carroll MW; Moss B; Rosenberg SA; Restifo NP
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2982-7. PubMed ID: 10077623
[TBL] [Abstract] [Full Text] [Related]
16. In vivo studies of the new gonadotropin-releasing hormone antagonist--copolymer conjugates having antitumor activity.
Vincze B; Pályi I; Gaál D; Pató J; Móra M; Mezõ I; Teplán I; Seprõdi J
Cancer Detect Prev; 1996; 20(2):153-9. PubMed ID: 8706041
[TBL] [Abstract] [Full Text] [Related]
17. Effect of gonadotropin-releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor--positive human cancer cell lines.
Pályi I; Vincze B; Kálnay A; Turi G; Mezõ I; Teplán I; Seprõdi J; Pató J; Móra M
Cancer Detect Prev; 1996; 20(2):146-52. PubMed ID: 8706040
[TBL] [Abstract] [Full Text] [Related]
18. Antitumour effect of a gonadotropin-releasing-hormone antagonist (MI-1544) and its conjugate on human breast cancer cells and their xenografts.
Vincze B; Pályi I; Daubner D; Kálnay A; Mezö G; Hudecz F; Szekerke M; Teplán I; Mezö I
J Cancer Res Clin Oncol; 1994; 120(10):578-84. PubMed ID: 7929528
[TBL] [Abstract] [Full Text] [Related]
19. Thrombospondin levels in patients with malignancy.
Tuszynski GP; Smith M; Rothman VL; Capuzzi DM; Joseph RR; Katz J; Besa EC; Treat J; Switalska HI
Thromb Haemost; 1992 Jun; 67(6):607-11. PubMed ID: 1509400
[TBL] [Abstract] [Full Text] [Related]
